Boris Gorelik
Vermogen: - $ op 31-08-2026
Vermogen: - $ op 31-08-2026
Boris Gorelik is currently VP-Business Development & Strategic Programs at Kamada Ltd. since 2022.
Formerly, Mr. Gorelik was Senior Director-Corporate Business Development at Teva Pharmaceutical Industries Ltd. and Chief Financial Officer at Nextgen Biomed Ltd. from 2016 to 2019.
Education includes undergraduate, graduate, and MBA degrees from Tel-Aviv University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
KAMADA LTD -.--% | 07-04-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| KAMADA LTD. | Corporate Officer/Principal | 01-04-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| NEXTGEN BIOMED LTD | Financieel Directeur/CFO | 31-07-2019 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Nextgen Biomed Ltd.
Nextgen Biomed Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures skin diseases pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau